SCHEMBL129237

SCHEMBL129237

[C]#CC(C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL387477 0.82
SCHEMBL386463 0.80
SCHEMBL7628906 0.78 OPRM1 (0.44)
SCHEMBL383851 0.78 OPRM1 (0.44)
SCHEMBL29588132 0.73 TSHR (0.38)
SCHEMBL24468 0.73
SCHEMBL1694080 0.71
SCHEMBL8694262 0.71
SCHEMBL29103327 0.71
SCHEMBL387860 0.71 LMNA (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4387629-A1 6-SUBSTITUTED- AND 6,7-DISUBSTITUTED-7-DEAZAPURINE RIBONUCLEOSIDE ANALOGUES Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2024-06-26 EP claimed
WO-2023021132-A1 6-SUBSTITUTED- AND 6,7-DISUBSTITUTED-7-DEAZAPURINE RIBONUCLEOSIDE ANALOGUES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-02-23 WO claimed
WO-1995019354-A1 3-ARYL ALKENYL-1,2,4-OXADIAZOLE DERIVATIVES AND THEIR USE AS PARASITICIDES FOR ANIMALS BAYER AKTIENGESELLSCHAFT (DE) 1995-07-20 WO claimed
CN-118302418-A Aromatic heterocyclic compound and application thereof 中国科学院上海药物研究所 2024-07-05 CN disclosed
EP-4393907-A1 POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION Neushen Therapeutics (Shanghai) Co., Ltd (CN) 2024-07-03 EP disclosed
CN-114126606-B Method for dispersing a biofilm comprising gram-negative bacteria Q生物股份有限公司 2024-06-21 CN disclosed
EP-4365178-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF, AND APPLICATION THEREOF Shanghai Allist Pharmaceuticals Co., Ltd. (CN) 2024-05-08 EP disclosed
CN-117832494-A Battery cell 珠海冠宇电池股份有限公司 2024-04-05 CN disclosed
EP-4342892-A1 BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF Hangzhou Healzen Therapeutics Co., Ltd. (CN) 2024-03-27 EP disclosed
CN-114867707-B Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium 株式会社力森诺科 2024-03-08 CN disclosed
CN-117642407-A Nitrogen-containing heterocyclic compound, preparation method, intermediate and application thereof 上海艾力斯医药科技股份有限公司 2024-03-01 CN disclosed
EP-0344197-A1 NOVEL N-1 SUBSTITUTED BETA-LACTAMS AS ANTIBIOTICS. UPJOHN CO (US) 1989-12-06 EP disclosed
EP-0337637-A1 2-(Heterocyclylthio)carbapenem derivatives their preparation and their use as antibiotics Sankyo Company Limited (JP) 1989-10-18 EP disclosed
EP-0318860-A2 Substituted alkylamine derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-06-07 EP disclosed
WO-1989000569-A1 THERAPEUTICALLY USEFUL beta-LACTAMS THE UPJOHN COMPANY (US) 1989-01-26 WO disclosed
EP-0300636-A1 Therapeutically useful beta-lactams THE UPJOHN COMPANY (US) 1989-01-25 EP disclosed
EP-0281289-A1 Antibiotic sulfonylaminocarbonyl activated beta-lactams THE UPJOHN COMPANY (US) 1988-09-07 EP disclosed
WO-1988006588-A1 ANTIBIOTIC SULFONYLAMINOCARBONYL ACTIVATED beta-LACTAMS THE UPJOHN COMPANY (US) 1988-09-07 WO disclosed
WO-1988006587-A1 ANTIBIOTIC beta-LACTAMS CONTAINING A PYRIDONE CARBOXYLIC ACID OR ACID DERIVATIVE THE UPJOHN COMPANY (US) 1988-09-07 WO disclosed
WO-1988006156-A1 NOVEL N-1 SUBSTITUTED beta-LACTAMS AS ANTIBIOTICS THE UPJOHN COMPANY (US) 1988-08-25 WO disclosed